Drugs News and Research

RSS

Cost cutting measures and patent expirations to propel the European generics and biogenerics market

The upcoming spate of patent expirations bodes well for the European generics market. The growing loss of patent protection on blockbuster brands over the next few years, coupled with the rising need to contain spiralling healthcare costs, is set to provide a fillip to market expansion.

19 Oct 2004

Discovery might improve design, effectiveness of anti-cancer drugs

Working with an enzyme that degrades anti-cancer drugs in humans, University of North Carolina at Chapel Hill biochemists and colleagues have made a discovery that they believe eventually could help improve such drugs’ design and effectiveness.

18 Oct 2004

Patients with chronic rhinosinusitis do not necessarily develop resistance to antibiotics

Patients with chronic rhinosinusitis (CRS, inflammation of the nasal passages and sinuses) do not necessarily develop resistance to antibiotics although they may be treated for long periods of time with these drugs

18 Oct 2004

One in four deaths among women with heart failure can be attributed to kidney problems

About one in four deaths among women with heart failure can be attributed to kidney problems, and more deaths are linked to renal insufficiency than to any other single risk factor, according to a new study in the Oct. 19, 2004 issue of the Journal of the American College of Cardiology.

18 Oct 2004

FDA issues warning on adolescent use of antidepressants

The Food and Drug Administration (FDA) has issued a Public Health Advisory announcing a multi-pronged strategy to warn the public about the increased risk of suicidal thoughts and behavior ("suicidality") in children and adolescents being treated with antidepressant medications.

18 Oct 2004

Researchers have found two areas of the brain that appear to compete for control over behavior

You walk into a room and spy a plate of gooey doughnuts dripping with chocolate frosting. But wait: You were saving your sweets allotment for a party later today. If it feels like one part of your brain is battling another, it probably is, according to a newly published study.

18 Oct 2004

Study underscores the relative safety of infliximab, when used properly

Rheumatoid arthritis patients receiving the recommended starting dose (3mg/kg) of infliximab (REMICADE®) have no more serious rate of infections than do patients taking methotrexate alone

18 Oct 2004

Presentation of the most recent and advanced work in the rapidly progressing field of fertility preservation

Each year approximately 50,000 women under the age of 40 are diagnosed with breast cancer. Treatments vary but most involve the administration of chemotherapeutic agents or radiation which can disrupt ovarian function or damage a patient’s eggs.

18 Oct 2004

COX-2 agents have influenced the way physicians prescribe rheumatology medication

COX-2 agents, with their perceived reduction in side effects, have contributed substantially to a dramatic increase in NSAIDs (non-steroidal anti-inflammatory drugs) prescription utilization and influenced the way physicians prescribe rheumatology medication

18 Oct 2004

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Rheumatoid arthritis patients have an approximately two-fold increased morbidity and mortality in infections compared to a population without the disease.

18 Oct 2004

Researchers have developed a novel drug-antidote pair

In a discovery that could give physicians more control over the actions of medications, researchers at Duke University Medical Center have developed a novel drug pair – a potent anti-coagulant with a matched "antidote."

18 Oct 2004

Significant steps to fight a deadly childhood muscle cancer

University of Utah scientists have taken significant steps to fight a deadly childhood muscle cancer by identifying some of the genetic events that cause the disease and then engineering mice that develop the tumors.

16 Oct 2004

Insulin sensitizing drugs help thin women as well overweight women with polycystic ovary syndrome

Insulin-sensitizing drugs can help thin women with polycystic ovary syndrome even if they do not appear to be insulin resistant, broadening the range of women who can benefit from the therapy, a Virginia Commonwealth University researcher said in this month’s issue of the journal Fertility and Sterility.

16 Oct 2004

Great breakthrough in cancer diagnostics

An amazingly sensitive method for selective analysis of amino acids, sugars, fatty acids, and other vital compounds has been developed by Russian scientists.

16 Oct 2004

Report challenges the British government's drug strategy

The findings show that the majority of drug addicts contacting drug treatment services in Scotland are looking to achieve abstinence rather than to receive advice on harm reduction from treatment services.

13 Oct 2004

Asthma research company Synairgen to float on London's Alternative Investment Market

A spin-out company from the University of Southampton specialising in finding and out-licensing treatments for chronic bronchitis (COPD) and the severest forms of asthma, is about to seek a listing on London's Alternative Investment Market (AIM).

13 Oct 2004

PAHO reports on the care and treatment of people with HIV in the Americas

The Pan American Health Organization (PAHO) has issued reports on the first seven of 47 countries and territories with new and specific data on the care and treatment of people with HIV in the Americas.

13 Oct 2004

University of Cambridge executes exclusive patent licences and collaborative research and development agreement with Gene Networks International

The University of Cambridge has entered into two licence agreements with Gene Networks International (GNI), granting exclusive rights to Cambridge's intellectual property related to angiogenesis (the growth of new blood vessels) and inflammation that may have implications in the identification of new drug targets for a range of diseases.

13 Oct 2004

Anti-epilepsy drug sodium valproate is associated with developmental delay and lower IQ

Around five in every 1000 people will have epilepsy. One in three people with epilepsy is a woman of childbearing age, and one in every 200 women attending antenatal clinics is being treated with anti-epileptic drugs.

13 Oct 2004

Researchers stimulate the body to repair tissue damaged by peripheral arterial obstructive disease

Duke University Medical Center researchers have shown that they can stimulate the body to produce its own naturally occurring growth factors to promote blood vessel growth into tissue damaged by peripheral arterial obstructive disease (PAOD).

13 Oct 2004

Drugs News and Research

Cost cutting measures and patent expirations to propel the European generics and biogenerics market

Discovery might improve design, effectiveness of anti-cancer drugs

Patients with chronic rhinosinusitis do not necessarily develop resistance to antibiotics

One in four deaths among women with heart failure can be attributed to kidney problems

FDA issues warning on adolescent use of antidepressants

Researchers have found two areas of the brain that appear to compete for control over behavior

Study underscores the relative safety of infliximab, when used properly

Presentation of the most recent and advanced work in the rapidly progressing field of fertility preservation

COX-2 agents have influenced the way physicians prescribe rheumatology medication

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Researchers have developed a novel drug-antidote pair

Significant steps to fight a deadly childhood muscle cancer

Insulin sensitizing drugs help thin women as well overweight women with polycystic ovary syndrome

Great breakthrough in cancer diagnostics

Report challenges the British government's drug strategy

Asthma research company Synairgen to float on London's Alternative Investment Market

PAHO reports on the care and treatment of people with HIV in the Americas

University of Cambridge executes exclusive patent licences and collaborative research and development agreement with Gene Networks International

Anti-epilepsy drug sodium valproate is associated with developmental delay and lower IQ

Researchers stimulate the body to repair tissue damaged by peripheral arterial obstructive disease

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News